Top Markets
Coin of the day
MGC Pharmaceuticals Limited MGC Pharmaceuticals Limited

MGC Pharmaceuticals Limited

MXC
Rang in aandelen #39836
MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established... MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established in West Perth in 2014, focuses on the worldwide development and distribution of plant-derived medicines. Its product portfolio encompasses both medicinal cannabis solutions and other botanical therapeutics. The company's key investigational treatments include CimetrA, currently in Phase III clinical trials for the symptomatic relief of early-stage COVID-19; CannEpil, a cannabis-based therapy undergoing Phase IIb studies for drug-resistant epilepsy; and CogniCann, which is in Phase II clinical development for alleviating dementia symptoms. Beyond these core candidates, MGC Pharmaceuticals also supplies the ArtemiC range, various other cannabinoid-infused products, and non-pharmaceutical items. Additionally, the company provides expert consulting services, particularly in clinical research. The company was previously named Erin Resources Limited before adopting its current identity, MGC Pharmaceuticals Limited, in December 2015.
Aandeelprijs
$0.27239819
Laatst gesynchroniseerd: 2024-04-29
Marktkapitalisatie
$330.42K
Verandering (1 dag)
0.52%
Verandering (1 jaar)
0.00%
Land
AU
Handel MGC Pharmaceuticals Limited (MXC)

Categorie

Koersgeschiedenis voor MGC Pharmaceuticals Limited (MXC)
Hoogste slotkoers: $0.28 op 2024-04-01

Laagste slotkoers: $2.78K op 2006-12-01
Koersgeschiedenis van MGC Pharmaceuticals Limited van 2006 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 -20.50%
2023 -95.74%
2022 -70.28%
2021 35.68%
2020 -7.75%
2019 -21.06%
2018 -56.01%
2017 99.41%
2016 67.92%
2015 355.81%
2014 -42.45%
2013 -89.52%
2012 -24.78%
2011 -23.17%
2010 -58.79%
2009 -24.92%
2008 -74.35%
2007 -46.31%
2006 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$171.67 -
DE
$165.47 28.01%
DE
$36.75 24.42%
JP
$232.21 43.16%
CH
$21.19 13.21%
IN